Results 31 to 40 of about 1,417,901 (252)
Cost-utility analysis of thrombolytic therapy [PDF]
European Heart Journal, 1991 An analysis of the cost-effectiveness of thrombolytic therapy was performed, based on 3- to 5-year follow-up data, from 533 patients randomized to receive conventional therapy or intracoronary streptokinase. At the 3-year follow-up, mortality was 22% in the former group and 14% after thrombolysis.
M L, Simoons, J, Vos, L L, Martens
openaire +2 more sources
Economic evaluation of using pesticides to control cutaneous leishmaniasis in Isfahan
Journal of Research in Pharmacy Practice, 2018 Objective: Pesticides have been used as the main part of the national cutaneous leishmaniasis control program for serveral years in Iran. However, the cost-effectiveness of this strategy has not been yet analyzed.
Ehsanallah Jafari +3 more
doaj +1 more source
Health Technology Assessment, 2023 Background Acamprosate is an effective and cost-effective medication for alcohol relapse prevention but poor adherence can limit its full benefit. Effective interventions to support adherence to acamprosate are therefore needed.
Kim Donoghue +25 more
doaj +1 more source
Cost-utility analysis in Alsheimer´s disease [PDF]
, 2010 Alzheimer s disease (AD) is a neurodegenerative disorder causing dementia, a syndrome of gradual loss of cognitive function causing impairment in social and occupational functioning.
Gustavsson, Anders
core +1 more source
Cost-effectiveness of primary debulking surgery when compared to neoadjuvant chemotherapy in the management of stage IIIC and IV epithelial ovarian cancer. [PDF]
, 2016 ObjectivesTo examine the cost-effectiveness of primary debulking surgery (PDS) when compared to neoadjuvant chemotherapy (NACT) in the management of epithelial ovarian cancer (EOC) using Surveillance, Epidemiology, and End Results data linked to Medicare
Chang, Jenny +2 more
core +1 more source
BMC Medical Informatics and Decision Making, 2021 Background Tumor necrosis factor α inhibitors (TNFi) is effective for rheumatoid arthritis (RA) patients who fail to conventional synthetic disease-modifying anti-rheumatic drugs (csDMARDs).
Juan Zhao +6 more
doaj +1 more source
A Systematic Review of Economic Evaluations of Active Tuberculosis Treatments
Frontiers in Pharmacology, 2021 Background: The disease burden of active tuberculosis (TB) is considerable, but systematic reviews of economic evaluations of active TB treatments are scarce.Methods: PubMed, EMBASE, and the Cochrane Library databases were used to search for articles on ...
Joo-Young Byun +3 more
doaj +1 more source
A note on the nature of utility in time and health and implications for cost utility analysis [PDF]
, 2008 Time Trade-Off valuations of health are widely used in economic evaluation of health care. Current approaches to eliciting TTO values, and their use in economic evaluation, rests on specific assumptions about the way utility relates to time and health ...
Buckingham, K., Devlin, N.
core
Global & Regional Health Technology Assessment, 2022 Obiettivo: Questo studio ha lo scopo di valutare il rapporto costo-efficacia di ceftolozano/tazobactam rispetto a meropenem per il trattamento di pazienti con polmonite acquisita in ospedale (HABP) o polmonite associata a ventilazione meccanica (VABP ...
Francesco Saverio Mennini +5 more
doaj +1 more source
METHODS OF ANALYSIS OF THE EFFECTIVENESS OF PUBLIC SECTOR PROJECTS: FEATURES AND CONSTRAINTS [PDF]
Baltic Journal of Economic Studies, 2018 The purpose of the paper is to consider the main provisions of methods of analysis of the effectiveness of public sector projects. A number of issues remain controversial in the methodology of analysing costs and benefits.
Volodymyr Lipkan +2 more
doaj +1 more source